AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 11837227 — intervention group
Group type: COMPARATOR
Intervention: Non-smoking carriers of the S2 allele
Number of subjects: 59
Study 9566455 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention form with explicit decision-support tool
Number of subjects: 450
Study 9566455 — intervention group
Group type: COMPARATOR
Intervention: Control form
Number of subjects: 450
Study 7848670 — intervention group
Group type: EXPERIMENTAL
Intervention: Participant intervention (mailed reminder letter and refrigerator magnet)
Number of subjects: 0
Study 7848670 — intervention group
Group type: EXPERIMENTAL
Intervention: Physician intervention (mailed packet to participant's physician including letter, NCEP guidelines, and preaddressed postcard to mail to patient)
Number of subjects: 0
Study 7848670 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions (participant and physician)
Number of subjects: 0
Study 7848670 — intervention group
Group type: COMPARATOR
Intervention: Usual care group
Number of subjects: 0
Study 2564262 — intervention group
Group type: EXPERIMENTAL
Intervention: Vecuronium 50 micrograms/kg iv as the only muscle relaxant
Number of subjects: 28
Study 2564262 — intervention group
Group type: COMPARATOR
Intervention: Succinylcholine 1.5 mg/kg
Number of subjects: 28
Study 29573047 — intervention group
Group type: EXPERIMENTAL
Intervention: Siblings Coping Together (SibCT)
Number of subjects: 70
Study 29573047 — intervention group
Group type: COMPARATOR
Intervention: Attention Control Group (CG)
Number of subjects: 70
Study 28979957 — intervention group
Group type: EXPERIMENTAL
Intervention: Strawberry beverage prepared in milk
Number of subjects: 9
Study 28979957 — intervention group
Group type: COMPARATOR
Intervention: Strawberry beverage prepared in water
Number of subjects: 9
Study 28979957 — intervention group
Group type: EXPERIMENTAL
Intervention: Strawberry beverage prepared in milk without meal
Number of subjects: 9
Study 28979957 — intervention group
Group type: COMPARATOR
Intervention: Strawberry beverage prepared in water without meal
Number of subjects: 9
Study 26563009 — intervention group
Group type: EXPERIMENTAL
Intervention: Quantum Molecular Resonance Tonsillectomy (QMRT)
Number of subjects: 80
Study 26563009 — intervention group
Group type: COMPARATOR
Intervention: Blunt Dissection Tonsillectomy (BDT)
Number of subjects: 80
Study 24946658 — intervention group
Group type: EXPERIMENTAL
Intervention: Upright body position
Number of subjects: 20
Study 24946658 — intervention group
Group type: COMPARATOR
Intervention: Supine body position
Number of subjects: 20
Study 24946658 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher percentages of maximum pressure
Number of subjects: 20
Study 21439539 — intervention group
Group type: EXPERIMENTAL
Intervention: hs-CRP >2 mg/L and BMS
Number of subjects: 301
Study 21439539 — intervention group
Group type: EXPERIMENTAL
Intervention: hs-CRP >2 mg/L and DES
Number of subjects: 301
Study 21439539 — intervention group
Group type: EXPERIMENTAL
Intervention: hs-CRP ≤2 mg/L and BMS
Number of subjects: 301
Study 21439539 — intervention group
Group type: EXPERIMENTAL
Intervention: hs-CRP ≤2 mg/L and DES
Number of subjects: 301
Study 21439539 — intervention group
Group type: COMPARATOR
Intervention: BMS + CRP ≤2 mg/L
Number of subjects: 301
Study 18237536 — intervention group
Group type: EXPERIMENTAL
Intervention: Specific allergen nebulization (group B)
Number of subjects: 40
Study 18237536 — intervention group
Group type: COMPARATOR
Intervention: Normal saline nebulization (group A)
Number of subjects: 40
Study 16776767 — intervention group
Group type: EXPERIMENTAL
Intervention: New supported mandibular denture
Number of subjects: 18
Study 16776767 — intervention group
Group type: COMPARATOR
Intervention: Old unsupported denture
Number of subjects: 18
Study 16776767 — intervention group
Group type: COMPARATOR
Intervention: Magnet, ball, and bar-clip attachment types
Number of subjects: 18
Study 16776767 — intervention group
Group type: EXPERIMENTAL
Intervention: Implant treatment
Number of subjects: 18
Study 15342835 — intervention group
Group type: EXPERIMENTAL
Intervention: CPAP/PEEP
Number of subjects: 104
Study 15342835 — intervention group
Group type: COMPARATOR
Intervention: Control (no CPAP/PEEP)
Number of subjects: 104
Study 11264609 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal hysterectomy
Number of subjects: 80
Study 11264609 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic assisted vaginal hysterectomy
Number of subjects: 80
Study 9260735 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine (60 mg daily)
Number of subjects: 15
Study 9260735 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 8497701 — intervention group
Group type: EXPERIMENTAL
Intervention: Methotrexate 30 mg week-1
Number of subjects: 18
Study 8497701 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 3497943 — intervention group
Group type: EXPERIMENTAL
Intervention: Commercial latex agglutination kits (Directigen, Bactigen) for S. pneumoniae antigens in serum
Number of subjects: 44
Study 3497943 — intervention group
Group type: EXPERIMENTAL
Intervention: Commercial latex agglutination kits (Directigen, Bactigen) for H. influenzae type b antigens in serum and urine
Number of subjects: 44
Study 3497943 — intervention group
Group type: EXPERIMENTAL
Intervention: Commercial latex agglutination kits (Directigen, Bactigen) for S. pneumoniae antigens in urine
Number of subjects: 44
Study 3497943 — intervention group
Group type: EXPERIMENTAL
Intervention: Commercial latex agglutination kits (Directigen, Bactigen) for H. influenzae type b pneumonia
Number of subjects: 44
Study 3497943 — intervention group
Group type: EXPERIMENTAL
Intervention: Commercial latex agglutination kits (Directigen, Bactigen) for S. pneumoniae pneumonia
Number of subjects: 44
Study 29138275 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-h blood glucose measurement (≥8.6 mmol/L)
Number of subjects: 4867
Study 29138275 — intervention group
Group type: COMPARATOR
Intervention: 2-h blood glucose measurement (≥7.8 mmol/L)
Number of subjects: 4867
Study 29138275 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-h glucose measurement
Number of subjects: 4867
Study 25814780 — intervention group
Group type: EXPERIMENTAL
Intervention: Open flap debridement (OFD)
Number of subjects: 30
Study 25814780 — intervention group
Group type: COMPARATOR
Intervention: Control (periodontally healthy subjects)
Number of subjects: 30
Study 23636241 — intervention group
Group type: EXPERIMENTAL
Intervention: Minced beef
Number of subjects: 10
Study 23636241 — intervention group
Group type: COMPARATOR
Intervention: Beef steak
Number of subjects: 10
Study 20886788 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture combined with western medicine (Simvastatin, Glipizide XL, Felodipine sustained-release tablets)
Number of subjects: 80
Study 20886788 — intervention group
Group type: COMPARATOR
Intervention: Western medicine only (Simvastatin, Glipizide XL, Felodipine sustained-release tablets)
Number of subjects: 80
Study 20886788 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison between groups after treatment
Number of subjects: 80
Study 18209515 — intervention group
Group type: EXPERIMENTAL
Intervention: Verum acupuncture (VA)
Number of subjects: 30
Study 18209515 — intervention group
Group type: COMPARATOR
Intervention: Sham acupuncture (SA)
Number of subjects: 30
Study 18209515 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined VA and SA
Number of subjects: 30
Study 17283935 — intervention group
Group type: EXPERIMENTAL
Intervention: Smelling group (odours were smelled)
Number of subjects: 3
Study 17283935 — intervention group
Group type: EXPERIMENTAL
Intervention: Imagining group (odours were imagined)
Number of subjects: 3
Study 17283935 — intervention group
Group type: COMPARATOR
Intervention: Meaning group (odour source names were compared)
Number of subjects: 3
Study 14625504 — intervention group
Group type: EXPERIMENTAL
Intervention: Soccer players
Number of subjects: 23
Study 14625504 — intervention group
Group type: COMPARATOR
Intervention: Control group (moderately active individuals)
Number of subjects: 23
Study 10981087 — intervention group
Group type: EXPERIMENTAL
Intervention: Lowering diastolic blood pressure to levels below 80 mm Hg in patients with diabetes
Number of subjects: 19000
Study 10981087 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose aspirin therapy in patients with hypertension
Number of subjects: 19000
Study 10981087 — intervention group
Group type: COMPARATOR
Intervention: Reduction of diastolic blood pressure to less than 90 mm Hg
Number of subjects: 19000
Study 10981087 — intervention group
Group type: EXPERIMENTAL
Intervention: Diastolic blood pressure of 83 mm Hg
Number of subjects: 19000
Study 8877020 — intervention group
Group type: EXPERIMENTAL
Intervention: Metamizol 25 mg kg‐1
Number of subjects: 104
Study 8877020 — intervention group
Group type: EXPERIMENTAL
Intervention: Pethidine 0.4 mg kg‐1
Number of subjects: 104
Study 8877020 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 104
Study 1890910 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicardipine (60‐120 mg daily)
Number of subjects: 30
Study 1890910 — intervention group
Group type: COMPARATOR
Intervention: Propranolol (120‐240 mg daily)
Number of subjects: 30
Study 6366719 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine (600 mg/m2 body surface/day for 4 months)
Number of subjects: 38
Study 6366719 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study 6366719 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine
Number of subjects: 38
Study 29266194 — intervention group
Group type: EXPERIMENTAL
Intervention: Conflictual discussion with marital partner
Number of subjects: 117
Study 29266194 — intervention group
Group type: COMPARATOR
Intervention: Positive discussion with marital partner
Number of subjects: 117
Study 30477842 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin A supplementation (25,000 IU/day for two months)
Number of subjects: 150
Study 30477842 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin A supplementation
Number of subjects: 150
Study 26832632 — intervention group
Group type: EXPERIMENTAL
Intervention: Rehabilitation with visual stimuli using digital video disk (DVD)
Number of subjects: 40
Study 26832632 — intervention group
Group type: COMPARATOR
Intervention: Cawthorne‐Cooksey exercises
Number of subjects: 40
Study 24170559 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimedia educational program (15 minutes)
Number of subjects: 108
Study 24170559 — intervention group
Group type: COMPARATOR
Intervention: Educational literature
Number of subjects: 108
Study 21345620 — intervention group
Group type: EXPERIMENTAL
Intervention: Forward-planned intensity-modulated radiotherapy (IMRT)
Number of subjects: 1145
Study 21345620 — intervention group
Group type: COMPARATOR
Intervention: Standard radiotherapy (RT)
Number of subjects: 1145
Study 20038244 — intervention group
Group type: COMPARATOR
Intervention: Fluconazole (1200 mg per day) alone
Number of subjects: 41
Study 20038244 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of fluconazole (1200 mg per day) and flucytosine (100 mg/kg per day) followed by fluconazole (800 mg per day)
Number of subjects: 41
Study 17209957 — intervention group
Group type: EXPERIMENTAL
Intervention: Smartsuction (SS)
Number of subjects: 54
Study 17209957 — intervention group
Group type: COMPARATOR
Intervention: Control (CTRL)
Number of subjects: 54
Study 15616799 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Fat (HF) Atkins Diet
Number of subjects: 96
Study 15616799 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Protein (HP) Zone Diet
Number of subjects: 96
Study 15616799 — intervention group
Group type: COMPARATOR
Intervention: High-Carbohydrate (HC) diet
Number of subjects: 96
Study 12004166 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous low-level heat wrap therapy (40 C, 8 hours/day)
Number of subjects: 371
Study 10442945 — intervention group
Group type: EXPERIMENTAL
Intervention: Salivary endotoxin concentration in pediatric leukemia patients
Number of subjects: 12
Study 10442945 — intervention group
Group type: COMPARATOR
Intervention: Healthy children (control group)
Number of subjects: 12
Study 8588015 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental referral procedure involving home visits by a community nurse to assess reasons for non-compliance and motivate compliance.
Number of subjects: 0
Study 8588015 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental referral procedure
Number of subjects: 0
Study 8588015 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly detailed in the abstract)
Number of subjects: 0
Study 2361812 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet (D)
Number of subjects: 44
Study 2361812 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet-Exercise (DE)
Number of subjects: 44
Study 2361812 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise (EX)
Number of subjects: 44
Study 2361812 — intervention group
Group type: COMPARATOR
Intervention: Non-exercising subjects (from D and DE)
Number of subjects: 44
Study 2361812 — intervention group
Group type: COMPARATOR
Intervention: Diet (D) and Diet-Exercise (DE)
Number of subjects: 44
Study 369652 — intervention group
Group type: EXPERIMENTAL
Intervention: Tienilic acid 250 mg
Number of subjects: 13
Study 369652 — intervention group
Group type: EXPERIMENTAL
Intervention: Bendrofluazide 5 mg
Number of subjects: 13
Study 369652 — intervention group
Group type: EXPERIMENTAL
Intervention: Spironolactone 100 mg
Number of subjects: 13
Study 369652 — intervention group
Group type: COMPARATOR
Intervention: All three drugs
Number of subjects: 13
Study 369652 — intervention group
Group type: EXPERIMENTAL
Intervention: Bendrofluazide and Tienilic acid
Number of subjects: 13
Study 369652 — intervention group
Group type: COMPARATOR
Intervention: Other two agents (Bendrofluazide and Spironolactone)
Number of subjects: 13
Study 31208509 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose caffeine (10 mg/kg maintenance dose after 20 mg/kg loading dose)
Number of subjects: 78
Study 31208509 — intervention group
Group type: COMPARATOR
Intervention: Low-dose caffeine (5 mg/kg maintenance dose after 20 mg/kg loading dose)
Number of subjects: 78
Study 31208509 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose caffeine
Number of subjects: 78
Study 28221719 — intervention group
Group type: EXPERIMENTAL
Intervention: Bouncing
Number of subjects: 150
Study 28221719 — intervention group
Group type: EXPERIMENTAL
Intervention: Assisted Autogenic Drainage (AAD)
Number of subjects: 150
Study 28221719 — intervention group
Group type: EXPERIMENTAL
Intervention: Bouncing combined with AAD (BAAD)
Number of subjects: 150
Study 26731724 — intervention group
Group type: EXPERIMENTAL
Intervention: Temsirolimus (25mg weekly IV infusions)
Number of subjects: 44
Study 25086478 — intervention group
Group type: EXPERIMENTAL
Intervention: Resorbable screws (Inion CPS)
Number of subjects: 101
Study 25086478 — intervention group
Group type: COMPARATOR
Intervention: Titanium screws (Stryker)
Number of subjects: 101
Study 22000411 — intervention group
Group type: EXPERIMENTAL
Intervention: Arthroscopic rotator cuff repair with a transtendon technique (group I)
Number of subjects: 48
Study 22000411 — intervention group
Group type: EXPERIMENTAL
Intervention: Arthroscopic rotator cuff repairs after tear completion (group II)
Number of subjects: 48
Study 19321228 — intervention group
Group type: EXPERIMENTAL
Intervention: CPR+AED
Number of subjects: 993
Study 19321228 — intervention group
Group type: COMPARATOR
Intervention: CPR only
Number of subjects: 993
Study 17552372 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavior Therapy (CBT)
Number of subjects: 201
Study 17552372 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 201
Study 17122357 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal leptin delivery; superpotent leptin-receptor agonists; manipulation of SOCS-3, PTP-1B, ciliary neurotrophic factor; traditional interventions for weight loss.
Number of subjects: 0
Study 17122357 — intervention group
Group type: EXPERIMENTAL
Intervention: Activation of melanocortin receptors; activation of 5-HT2C and 5-HT1B receptors.
Number of subjects: 0
Study 17122357 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhibition of neuropeptide Y, melanin-concentrating hormone, ghrelin, and endocannabinoids.
Number of subjects: 0
Study 17122357 — intervention group
Group type: EXPERIMENTAL
Intervention: Modulation of gastrointestinal satiation and hunger signals.
Number of subjects: 0
Study 12218750 — intervention group
Group type: EXPERIMENTAL
Intervention: Shoe with high material hardness
Number of subjects: 6
Study 12218750 — intervention group
Group type: COMPARATOR
Intervention: Shoe with low material hardness
Number of subjects: 6
Study 10543929 — intervention group
Group type: EXPERIMENTAL
Intervention: Inogatran (low molecular mass direct thrombin inhibitor)
Number of subjects: 1209
Study 10543929 — intervention group
Group type: COMPARATOR
Intervention: Unfractionated heparin
Number of subjects: 1209
Study 7843899 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher levels of beta-carotene in serum
Number of subjects: 400
Study 7843899 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher levels of alpha-carotene, beta-cryptoxanthin, and lutein in serum
Number of subjects: 400
Study 7843899 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher levels of carotenoids and alpha-tocopherol
Number of subjects: 400
Study 7843899 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall serum levels of carotenoids and tocopherols
Number of subjects: 400
Study 2201795 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose (100 million units) recombinant alpha‐2b‐interferon
Number of subjects: 87
Study 2201795 — intervention group
Group type: COMPARATOR
Intervention: Low dose (10 million units) recombinant alpha‐2b‐interferon
Number of subjects: 87
Study 189334 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg ACTH 4-10
Number of subjects: 24
Study 189334 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 mg ACTH 4-10
Number of subjects: 24
Study 189334 — intervention group
Group type: COMPARATOR
Intervention: matched placebo
Number of subjects: 24
Study 31974857 — intervention group
Group type: EXPERIMENTAL
Intervention: 10:4 training group (10 s work bouts with 4 min of rest, n=11)
Number of subjects: 42
Study 31974857 — intervention group
Group type: COMPARATOR
Intervention: CON (control group, n=10)
Number of subjects: 42
Study 31974857 — intervention group
Group type: EXPERIMENTAL
Intervention: 10:2 training group (10 s work bouts with 2 min of rest, n=11)
Number of subjects: 42
Study 31974857 — intervention group
Group type: EXPERIMENTAL
Intervention: 30:4 training group (30 s work bouts with 4 min of rest, n=10)
Number of subjects: 42
Study 31288177 — intervention group
Group type: EXPERIMENTAL
Intervention: VEGF-A165/bFGF plasmid (VIF) administered via electromechanical system NOGA-guided intramyocardial injections into ischemic regions.
Number of subjects: 52
Study 31288177 — intervention group
Group type: COMPARATOR
Intervention: Placebo plasmid injections.
Number of subjects: 52
Study 31288177 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (VIF and Placebo).
Number of subjects: 52
Study 28374466 — intervention group
Group type: EXPERIMENTAL
Intervention: Local infiltration analgesia (LIA) - 156 ml of a mixture of 0.2% ropivacaine + 30 mg ketorolac + 0.5 mg (5 ml) adrenaline
Number of subjects: 59
Study 28374466 — intervention group
Group type: COMPARATOR
Intervention: Saline and intravenous ketorolac (Control)
Number of subjects: 59
Study 28374466 — intervention group
Group type: EXPERIMENTAL
Intervention: Local infiltration analgesia (LIA)
Number of subjects: 59
Study 26502272 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold applied immediately after exercise
Number of subjects: 100
Study 26502272 — intervention group
Group type: EXPERIMENTAL
Intervention: Heat applied immediately after exercise
Number of subjects: 100
Study 26502272 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold applied 24 hours after exercise
Number of subjects: 100
Study 26502272 — intervention group
Group type: EXPERIMENTAL
Intervention: Heat applied 24 hours after exercise
Number of subjects: 100
Study 26502272 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 100
Study 23523986 — intervention group
Group type: EXPERIMENTAL
Intervention: SLI group
Number of subjects: 14
Study 23523986 — intervention group
Group type: COMPARATOR
Intervention: TD group
Number of subjects: 14
Study 21740243 — intervention group
Group type: EXPERIMENTAL
Intervention: Sc+ES+S+V
Number of subjects: 96
Study 21740243 — intervention group
Group type: EXPERIMENTAL
Intervention: Sc+ES+EO+V
Number of subjects: 96
Study 21740243 — intervention group
Group type: EXPERIMENTAL
Intervention: Sb+AP+PP+CstO
Number of subjects: 96
Study 21740243 — intervention group
Group type: COMPARATOR
Intervention: SC+ES+V
Number of subjects: 96
Study 21740243 — intervention group
Group type: EXPERIMENTAL
Intervention: Etch+Sc+ES+S+Us
Number of subjects: 96
Study 21740243 — intervention group
Group type: EXPERIMENTAL
Intervention: Sc+ES+S+Fb+V+Fb
Number of subjects: 96
Study 19128928 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal cord stimulation (SCS)
Number of subjects: 332
Study 19128928 — intervention group
Group type: COMPARATOR
Intervention: Best medical treatment alone
Number of subjects: 332
Study 16362558 — intervention group
Group type: COMPARATOR
Intervention: Conventional pelvic floor muscle exercises
Number of subjects: 377
Study 16362558 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital vaginal control
Number of subjects: 377
Study 10499079 — intervention group
Group type: EXPERIMENTAL
Intervention: Insecticide-treated curtains (ITC)
Number of subjects: 763
Study 7582282 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled wild‐type rhinovirus 16 (RV16) administered at a total dose of 3 x 10(4) TCID50
Number of subjects: 14
Study 7582282 — intervention group
Group type: COMPARATOR
Intervention: Placebo administered in equal doses into both nostrils
Number of subjects: 14
Study 7582282 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled methacholine
Number of subjects: 14
Study 1782971 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled budesonide (0.8, 1.6, and 3.2 mg/day)
Number of subjects: 12
Study 1782971 — intervention group
Group type: COMPARATOR
Intervention: Oral prednisolone (5, 10, and 20 mg/day)
Number of subjects: 12
Study 1782971 — intervention group
Group type: EXPERIMENTAL
Intervention: Both inhaled budesonide and oral prednisolone
Number of subjects: 12
Study 6959170 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate
Number of subjects: 4
Study 6959170 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4
Study 31940543 — intervention group
Group type: EXPERIMENTAL
Intervention: GBDT (Gradient Boosting Decision Tree)
Number of subjects: 30